NEWS

Alliance SOLARIS Trial: Vitamin D3 Fails to Boost Colorectal Cancer Survival

August 13, 2026 - For patients with advanced colorectal cancer, adding high-dose vitamin D3 to standard first-line treatment does not improve progression-free survival, according to the results from the Phase III SOLARIS trial (Alliance A021703) published in the Journal of the American Medical Association.

Experimental evidence has suggested that vitamin D may have antineoplastic activity, including effe


July Media Mentions: Sharing News from the Alliance in the Media

August 4, 2026 - The media relations efforts from Alliance staff and researchers are designed to alert the public about the vital work happening across our network. When we share stories about clinical trial results, scientific milestones, or investigator achievements, we are showcasing the real-world progress you help make possible.

More than just news mentions, these media stories serve a crucial purpose for the o


Alliance QUANTUM Trial to Study Bispecific Immunotherapy for Rare Leukemia
New trial evaluates whether post-transplant consolidation therapy with teclistamab can improve survival in patients with primary plasma cell leukemia

July 30, 2026- The Alliance for Clinical Trials in Oncology today announced the activation of The QUANTUM Trial (Alliance A062401), a clinical study designed to test a novel, immune-targeting approach for patients newly diagnosed with primary plasma cell leukemia (P


Older News